Related Experiment Videos

Growth inhibitory effects of diallyl disulfide on human breast cancer cell lines

H Nakagawa1, K Tsuta, K Kiuchi

  • 1Department of Pathology II and Department of Surgery II, Kansai Medical University, Moriguchi, Osaka 570-8506, Japan.

Carcinogenesis
|May 29, 2001
PubMed

Insights

Diallyl disulfide (DADS), a compound found in garlic, effectively inhibits human breast cancer cell growth, both estrogen receptor-positive and -negative, by inducing apoptosis. DADS shows promise as an anticancer agent, demonstrating efficacy in both in vitro and in vivo models.

Area of Science:

  • Oncology
  • Biochemistry
  • Pharmacology

Background:

  • Diallyl disulfide (DADS) is an organosulfur compound present in garlic with potential therapeutic properties.
  • Breast cancer encompasses diverse subtypes, including estrogen receptor (ER)-positive and -negative, necessitating varied treatment strategies.
  • Understanding the mechanisms of novel compounds like DADS in modulating cancer cell proliferation is crucial for developing new therapies.

Purpose of the Study:

  • To investigate the anti-cancer effects of synthetic DADS on various human breast cancer cell lines.
  • To determine the impact of DADS on cell growth, apoptosis, and proliferation in both in vitro and in vivo settings.
  • To explore the interaction of DADS with specific fatty acids in modulating breast cancer cell behavior.

Main Methods:

  • In vitro MTT assays were conducted on ER-positive (KPL-1, MCF-7) and ER-negative (MDA-MB-231, MKL-F) human breast cancer cell lines to assess DADS's cytotoxic effects.
  • Apoptosis was analyzed by flow cytometry (sub G1 fraction) and Western blotting for key proteins (Bax, Bcl-X(L), caspase-3) in MDA-MB-231 cells.
  • In vivo efficacy was evaluated using orthotopic transplantation of KPL-1 cells in nude mice, with DADS administered intraperitoneally, and tumor growth/proliferation (PCNA-labeling) assessed.

Main Results:

  • DADS demonstrated significant growth inhibition across all tested cell lines, irrespective of ER status, with IC(50) values ranging from 1.8-18.1 microM after 72 hours.
  • Growth inhibition was attributed to apoptosis induction, evidenced by sub G1 fraction increase and modulation of apoptosis-related proteins (Bax, Bcl-X(L), caspase-3).
  • In vivo studies showed DADS significantly reduced primary tumor weight and cell proliferation (PCNA-labeling) in mice without apparent side effects. DADS also modulated the effects of linoleic acid and eicosapentaenoic acid on cancer cells.

Conclusions:

  • Diallyl disulfide exhibits potent anticancer activity against both hormone-dependent and -independent human breast cancer cells.
  • DADS induces apoptosis and reduces tumor growth and proliferation, suggesting its potential as a therapeutic agent.
  • DADS may synergize with certain polyunsaturated fatty acids, offering a potential complementary therapeutic strategy for breast cancer management.

Related Concept Videos